Novavax
NVAX
6,59 €
Share price
19.52%
Change (1 day)
68.26%
Change (1 year)
Categories
Revenue for Novavax (NVAX)
Revenue in 2024 (TTM): €0.63 Billion
According to Novavax's latest financial reports the company's current revenue (TTM 
) is €0.60 Billion. an increase over the revenue in the year 2023 that were of €0.62 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Novavax from 1996 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | €0.65 B | 4.5% |
| 2023 | €0.62 B | -51.71% |
| 2022 | €1.29 B | 28.34% |
| 2021 | €1.01 B | 161.77% |
| 2020 | €0.38 B | 2221.07% |
| 2019 | €16.65 M | -44.42% |
| 2018 | €29.97 M | 15.35% |
| 2017 | €25.98 M | 78.01% |
| 2016 | €14.59 M | -55.98% |
| 2015 | €33.15 M | 31.52% |
| 2014 | €25.2 M | 66.46% |
| 2013 | €15.14 M | -9.26% |
| 2012 | €16.68 M | 47.56% |
| 2011 | €11.31 M | 4285.99% |
| 2010 | €0.25 M | 13.68% |
| 2009 | €0.22 M | -70.19% |
| 2008 | €0.76 M | -14.84% |
| 2007 | €0.89 M | -74.82% |
| 2006 | €3.54 M | -43.09% |
| 2005 | €6.23 M | -5.2% |
| 2004 | €6.57 M | -29.73% |
| 2003 | €9.36 M | -31.1% |
| 2002 | €13.58 M | -50.14% |
| 2001 | €27.25 M | 937.22% |
| 2000 | €2.62 M | 120.31% |
| 1999 | €1.19 M | 102.16% |
| 1998 | €0.58 M | 16.67% |
| 1997 | €0.5 M | 100% |
| 1996 | €0.25 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | €91.22 M | -84.83% | 🇺🇸 USA |
 | €1.67 B | 178.82% | 🇺🇸 USA |
 | €0.89 B | 48.59% | 🇺🇸 USA |
 | €0.39 B | -33.93% | 🇺🇸 USA |
 | €47.67 B | 7,826.71% | 🇬🇧 UK |
 | €56.09 B | 9,227.11% | 🇺🇸 USA |
 | €45.60 B | 7,482.07% | 🇨🇭 Switzerland |
 | N/A | N/A | 🇺🇸 USA |
 | €35.42 B | 5,790.18% | 🇬🇧 UK |
 | €6.18 M | -98.97% | 🇺🇸 USA |